Association of polymorphisms in the β2 and β3 adrenoceptor gene with polycystic ovary syndrome

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 5, 2006, Pages 389-393

  Kurabayashi, Takumi ^a,b   Yahata, Tetsuro ^a   Quan, Jinhua ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA CITY GENERAL HOSPITAL   (Japan)

Author keywords

2 adrenoceptor; 3 adrenoceptor; Genetic polymorphisms; Polycystic ovary syndrome

Indexed keywords

BAR 2 PROTEIN; BAR 3 PROTEIN; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; GENE PRODUCT; GLUTAMINE; GLYCINE; UNCLASSIFIED DRUG;

ADULT; ALLELISM; ARTICLE; BAR 2 GENE; BAR 3 GENE; BODY MASS; BODY WEIGHT; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERLIPIDEMIA; INFERTILITY; INSULIN RESISTANCE; JAPAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; ASIAN; CASE CONTROL STUDY; FEMALE INFERTILITY; GENETIC PREDISPOSITION; GENETICS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CODON; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFERTILITY, FEMALE; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3;

EID: 33646756840     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Frank S: Polycystic ovary syndrome. N Engl J Med 1995;333:853-861
2. Dunaif A: Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med (suppl 1A) 1995;98:33S-39S
3. Gambineri A, Pelusi C, Vicennati V, et al: Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 2002;26:883-896
4. Nestler JE, Jakubowicz DJ, Evans WS, et al: Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998;338:1876-1880
5. Nestler JE, Stovall D, Akhter N, et al: Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 2002;77:209-215
6. Legro RS, Driscoll D, Strauss JF, et al: Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998;95:14956-14960
7. Legro RS, Bentley-Lewis R, Driscoll D, et al: Insulin resistance in the sisters of women with polycystic ovary syndrome: Association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 2002;87:2128-2133
8. Yildiz BO, Yarali H, Oguz H, et al: Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2031-2036
9. Liggett SB: Polymorphisms of the beta2-adrenergic receptor and asthma. Am J Respir Crit Care Med 1997;156:S156-S162
10. Green SA, Turki J, Hall IP, et al: Implications of genetic variability of human beta2-adrenergic receptor structure. Pulm Pharmacol 1995;8:1-10
11. Largett SD, Hellstrom L, Reynisdottir S, et al: Human β2-adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte β2-adrenoceptor function. J Clin Invest 1997;100:3005-3013
12. Hellstrom L, Large V, Reynisdottir S, et al: The different effects of a Gln27Glu β2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med 1999;245:253-259
13. Bronnikov G, Bengtsson T, Kramarova L, et al: Betal to β3 switch in control of cyclic adenosine monophosphate during brown adipocyte development explains distinct β-adrenoceptor subtype mediation of proliferation and differentiation. Endocrinology 1999;140:4185-4197
14. Surwit RS, Dixon TM, Petro AE, et al: Diazoxide restores β3-adrenergic receptor function in diet-induced obesity and diabetes. Endocrinology 2000;141:3630-3637
15. Walston J, Silver K, Bogardus C, et al: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene. N Engl J Med 1995;333:343-347
16. Widen E, Lehto M, Kanninen T, et al: Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-351
17. Kadowaki H, Yasuda K, Iwamoto K, et al: A mutation in β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995;215:555-560
18. Kurabayashi T, Carey DG, Morrison NA: The β3-adrenergic receptor gene Trp64Arg mutation is over represented in obese women: Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 1996;45:1358-1363
19. Sakane N, Yoshida T, Umekawa T, et al: β3-adrenergic receptor polymorphism: A genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 1997;40:200-204
20. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25
21. Seli E, Duleba AJ: Optimizing ovulation induction in women with polycystic ovary syndrome. Curr Opin Obstet Gynaecol 2000;14:245-254
22. McLaughlin T, Abbasi F, Cheal K, et al: Use of metabolic marker to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-809
23. Gharani N, Waterworth DM, Batty S, et al: Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997;6:397-402
24. Diamanti-Kandarakis E, Bartzis MI, Bergiele AT, et al: Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYPIl alpha influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril 2000;73:735-741
25. Urbanek M, Lagro RS, Driscoll DA, et al: Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 1999;96:8573-8578
26. Waterworth DM, Bennett ST, Gharani N, et al: Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997;349:986-990
27. Millan JLS, Corton M, Villuendas G, et al: Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 2004;89:2640-2646
28. Tucci S, Futterweit W, Concepcion ES, et al: Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab 2001;86:46-449
29. El Mkadem SA, Lautier C, Marcari F, et al: Role of allelic variants Gly972 Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome. Diabetes 2001;50:2164-2168
30. Dallongeville J, Helbecque N, Cottel D, et al: The Gly16→ Arg16 and Gln27→Glu27 polymorphisms of β2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 2003;88:4862-1866